AU2008322995B2 - Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener - Google Patents

Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener Download PDF

Info

Publication number
AU2008322995B2
AU2008322995B2 AU2008322995A AU2008322995A AU2008322995B2 AU 2008322995 B2 AU2008322995 B2 AU 2008322995B2 AU 2008322995 A AU2008322995 A AU 2008322995A AU 2008322995 A AU2008322995 A AU 2008322995A AU 2008322995 B2 AU2008322995 B2 AU 2008322995B2
Authority
AU
Australia
Prior art keywords
weight
paste
paste according
water
cyclodextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008322995A
Other languages
English (en)
Other versions
AU2008322995A1 (en
Inventor
Stefan Haas
Katrin Oppel
Susanne Christine Wieland-Berghausen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elanco Tiergesundheit AG
Original Assignee
Novartis Tiergesundheit AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Tiergesundheit AG filed Critical Novartis Tiergesundheit AG
Publication of AU2008322995A1 publication Critical patent/AU2008322995A1/en
Application granted granted Critical
Publication of AU2008322995B2 publication Critical patent/AU2008322995B2/en
Assigned to NOVARTIS TIERGESUNDHEIT AG reassignment NOVARTIS TIERGESUNDHEIT AG Request for Assignment Assignors: NOVARTIS AG
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2008322995A 2007-11-15 2008-11-12 Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener Ceased AU2008322995B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07120767.4 2007-11-15
EP07120767 2007-11-15
PCT/EP2008/065335 WO2009062939A1 (en) 2007-11-15 2008-11-12 Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener

Publications (2)

Publication Number Publication Date
AU2008322995A1 AU2008322995A1 (en) 2009-05-22
AU2008322995B2 true AU2008322995B2 (en) 2014-01-30

Family

ID=39092818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008322995A Ceased AU2008322995B2 (en) 2007-11-15 2008-11-12 Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener

Country Status (7)

Country Link
US (1) US20100286154A1 (enExample)
EP (1) EP2219643B1 (enExample)
JP (1) JP5319691B2 (enExample)
AU (1) AU2008322995B2 (enExample)
CA (1) CA2703008A1 (enExample)
ES (1) ES2385126T3 (enExample)
WO (1) WO2009062939A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201041508A (en) * 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity
GB2482526A (en) * 2010-08-05 2012-02-08 Fiona Anne Macdonald Praziquantel suspendable powder as an immersion fish treatment for parasites
EP2594258B1 (en) * 2011-11-18 2020-03-18 Veterinärmedizinische Universität Wien Oral gel comprising praziquantel
JP6499970B2 (ja) * 2013-10-30 2019-04-10 大蔵製薬株式会社 服用し易いゼリー状医薬組成物
GB2527555B (en) 2014-06-25 2018-09-19 Norbrook Lab Ltd Stable methimazole liquid compositions
RU2613490C2 (ru) * 2015-01-27 2017-03-16 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Композиция на основе R(-)-празиквантела для лечения и профилактики гельминтозов у теплокровных
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
DE102018002904A1 (de) 2018-04-09 2019-10-10 Marc de Cocq Die Verwendung von Praziquantel in Kombination mit Milbemycinen zur Behandlung von Fischen
CN109432440B (zh) * 2018-11-30 2022-04-26 佛山科学技术学院 一种吡喹酮羟丙基环糊精包合物及其制备方法和应用
RU2722272C1 (ru) * 2019-04-30 2020-05-28 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Средство для лечения и профилактики нематодозов и цестодозов у мелких домашних животных
WO2022034226A1 (en) * 2020-08-14 2022-02-17 Universidad De Navarra Avermectin and milbemycin compositions for inhalation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004000034A2 (en) * 2002-06-21 2003-12-31 Merial Limited Anthelmintic oral homogeneous veterinary pastes
WO2005062782A2 (en) * 2003-12-23 2005-07-14 Merial Limited Non-animal product containing veterinary formulations
WO2006011051A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447414A (en) * 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
EP0959891A1 (en) * 1996-07-30 1999-12-01 Ashmont Holdings Limited Anthelmintic formulations
GB9801109D0 (en) 1998-01-20 1998-03-18 Pfizer Cyclodextrin compositions
US6207179B1 (en) 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
PL372341A1 (en) * 2002-03-08 2005-07-11 Bayer Business Services Gmbh Antiparasitic artemisinin derivatives (endoperoxides)
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
CA2565159A1 (en) * 2004-05-06 2005-12-15 Cydex, Inc. Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin
AU2007100254B4 (en) 2007-03-29 2007-05-03 Jurox Pty Ltd Improved parasiticide paste

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004000034A2 (en) * 2002-06-21 2003-12-31 Merial Limited Anthelmintic oral homogeneous veterinary pastes
WO2005062782A2 (en) * 2003-12-23 2005-07-14 Merial Limited Non-animal product containing veterinary formulations
WO2006011051A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form

Also Published As

Publication number Publication date
JP2011503140A (ja) 2011-01-27
JP5319691B2 (ja) 2013-10-16
CA2703008A1 (en) 2009-05-22
AU2008322995A1 (en) 2009-05-22
WO2009062939A1 (en) 2009-05-22
US20100286154A1 (en) 2010-11-11
EP2219643A1 (en) 2010-08-25
ES2385126T3 (es) 2012-07-18
EP2219643B1 (en) 2012-05-16

Similar Documents

Publication Publication Date Title
AU2008322995B2 (en) Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
EP1263467B1 (en) Paste formulations comprising silica
AU2016208328B2 (en) Clay compositions
JP7223744B2 (ja) 獣医用途のためのデンプン不含のソフトチュー
CN114144172A (zh) 软咀嚼兽用剂型
MXPA05001825A (es) Formulaciones veterinarias que no contienen producto animal.
TW202412756A (zh) 包含sglt-2抑制劑之水性醫藥組合物
KR102681552B1 (ko) 소장 상피세포에서의 카테킨 흡수 증진제
DE60118132T2 (de) Anthelmintika
TWI259082B (en) Stable ribavirin syrup formulations
TW200942234A (en) Composition containing sesamins and quercetin glycoside
AU2006322120B2 (en) Benzimidazole non-aqueous compositions
WO2014150651A1 (en) Racecadotril liquid compositions
EP2135512B1 (de) Zusammensetzung auf der Basis von Äpfelsäure, Kaffeesäure, einem Flavan-3-ol und einem Anthocyan und ihre Verwendung in Lebensmitteln und Medizin
AU2007100254A4 (en) Improved parasiticide paste
EP1713468B9 (en) Anthelmintic composition
CN110121269A (zh) 用于肠细胞中的儿茶素摄取的增强剂
HK1181638B (en) Clay compositions
HK1181638A (en) Clay compositions

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: NOVARTIS TIERGESUNDHEIT AG

Free format text: FORMER OWNER WAS: NOVARTIS AG

MK14 Patent ceased section 143(a) (annual fees not paid) or expired